Pressure BioSciences, Inc. (PBIO)
USD 0.0
(-66.17%)
USD 0.0
(-66.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.97 Million USD | 14.36% |
| 2022 | 1.72 Million USD | -13.63% |
| 2021 | 2 Million USD | 64.05% |
| 2020 | 1.22 Million USD | -32.56% |
| 2019 | 1.8 Million USD | -26.36% |
| 2018 | 2.45 Million USD | 9.7% |
| 2017 | 2.24 Million USD | 13.36% |
| 2016 | 1.97 Million USD | 9.95% |
| 2015 | 1.79 Million USD | 30.77% |
| 2014 | 1.37 Million USD | -8.55% |
| 2013 | 1.5 Million USD | 21.41% |
| 2012 | 1.23 Million USD | 25.36% |
| 2011 | 987.72 Thousand USD | -26.29% |
| 2010 | 1.34 Million USD | 7.64% |
| 2009 | 1.24 Million USD | 46.07% |
| 2008 | 852.26 Thousand USD | 31.96% |
| 2007 | 645.87 Thousand USD | 207.13% |
| 2006 | 210.28 Thousand USD | 99.28% |
| 2005 | 105.52 Thousand USD | -74.43% |
| 2004 | 412.61 Thousand USD | -98.23% |
| 2003 | 23.29 Million USD | 2.33% |
| 2002 | 22.76 Million USD | 4.3% |
| 2001 | 21.82 Million USD | 12.1% |
| 2000 | 19.46 Million USD | -33.55% |
| 1999 | 29.3 Million USD | 12.26% |
| 1998 | 26.1 Million USD | 17.04% |
| 1997 | 22.3 Million USD | 43.87% |
| 1996 | 15.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 349.25 Thousand USD | 11.82% |
| 2023 Q2 | 511.8 Thousand USD | -30.89% |
| 2023 Q4 | 312.35 Thousand USD | -24.37% |
| 2023 Q3 | 413 Thousand USD | -19.3% |
| 2023 FY | 1.97 Million USD | 14.36% |
| 2023 Q1 | 740.6 Thousand USD | 21.97% |
| 2022 FY | 1.72 Million USD | -13.63% |
| 2022 Q2 | 498.13 Thousand USD | 3.78% |
| 2022 Q3 | 144.03 Thousand USD | -71.09% |
| 2022 Q4 | 607.17 Thousand USD | 321.55% |
| 2022 Q1 | 480 Thousand USD | 52.28% |
| 2021 FY | 2 Million USD | 64.05% |
| 2021 Q3 | 518.36 Thousand USD | -14.87% |
| 2021 Q1 | 559.87 Thousand USD | 239.93% |
| 2021 Q2 | 608.92 Thousand USD | 8.76% |
| 2021 Q4 | 315.19 Thousand USD | -39.19% |
| 2020 FY | 1.22 Million USD | -32.56% |
| 2020 Q1 | 253.87 Thousand USD | -9.31% |
| 2020 Q2 | 268.15 Thousand USD | 5.63% |
| 2020 Q3 | 533.86 Thousand USD | 99.09% |
| 2020 Q4 | 164.7 Thousand USD | -69.15% |
| 2019 Q2 | 518.66 Thousand USD | 1.65% |
| 2019 Q3 | 501.15 Thousand USD | -3.38% |
| 2019 Q4 | 279.93 Thousand USD | -44.14% |
| 2019 FY | 1.8 Million USD | -26.36% |
| 2019 Q1 | 510.24 Thousand USD | -25.68% |
| 2018 FY | 2.45 Million USD | 9.7% |
| 2018 Q4 | 686.55 Thousand USD | 31.58% |
| 2018 Q3 | 521.76 Thousand USD | -18.32% |
| 2018 Q2 | 638.77 Thousand USD | 4.58% |
| 2018 Q1 | 610.77 Thousand USD | 21.5% |
| 2017 Q2 | 540.37 Thousand USD | -1.99% |
| 2017 Q1 | 551.35 Thousand USD | 31.37% |
| 2017 FY | 2.24 Million USD | 13.36% |
| 2017 Q4 | 502.7 Thousand USD | -22.19% |
| 2017 Q3 | 646.06 Thousand USD | 19.56% |
| 2016 Q3 | 535.33 Thousand USD | 4.77% |
| 2016 FY | 1.97 Million USD | 9.95% |
| 2016 Q4 | 419.71 Thousand USD | -21.6% |
| 2016 Q1 | 510.47 Thousand USD | 40.2% |
| 2016 Q2 | 510.96 Thousand USD | 0.1% |
| 2015 Q1 | 440.13 Thousand USD | 51.46% |
| 2015 Q2 | 413.1 Thousand USD | -6.14% |
| 2015 FY | 1.79 Million USD | 30.77% |
| 2015 Q3 | 580.33 Thousand USD | 40.48% |
| 2015 Q4 | 364.11 Thousand USD | -37.26% |
| 2014 Q2 | 307.46 Thousand USD | -23.92% |
| 2014 Q4 | 290.58 Thousand USD | -22.0% |
| 2014 FY | 1.37 Million USD | -8.55% |
| 2014 Q1 | 404.14 Thousand USD | 14.15% |
| 2014 Q3 | 372.54 Thousand USD | 21.17% |
| 2013 Q4 | 354.05 Thousand USD | -15.85% |
| 2013 Q3 | 420.76 Thousand USD | 17.62% |
| 2013 FY | 1.5 Million USD | 21.41% |
| 2013 Q2 | 357.73 Thousand USD | -3.51% |
| 2013 Q1 | 370.73 Thousand USD | 71.61% |
| 2012 Q4 | 216.03 Thousand USD | -44.84% |
| 2012 Q2 | 324.9 Thousand USD | 6.3% |
| 2012 Q3 | 391.61 Thousand USD | 20.53% |
| 2012 Q1 | 305.66 Thousand USD | -9.02% |
| 2012 FY | 1.23 Million USD | 25.36% |
| 2011 Q3 | 280.42 Thousand USD | 47.06% |
| 2011 FY | 987.72 Thousand USD | -26.29% |
| 2011 Q4 | 335.97 Thousand USD | 19.81% |
| 2011 Q2 | 190.68 Thousand USD | 5.56% |
| 2011 Q1 | 180.64 Thousand USD | -34.31% |
| 2010 Q1 | 290.81 Thousand USD | -16.99% |
| 2010 FY | 1.34 Million USD | 7.64% |
| 2010 Q4 | 275.01 Thousand USD | -26.09% |
| 2010 Q3 | 372.1 Thousand USD | -7.46% |
| 2010 Q2 | 402.1 Thousand USD | 38.27% |
| 2009 Q4 | 350.34 Thousand USD | 10.37% |
| 2009 FY | 1.24 Million USD | 46.07% |
| 2009 Q1 | 306.76 Thousand USD | -8.17% |
| 2009 Q2 | 270.38 Thousand USD | -11.86% |
| 2009 Q3 | 317.42 Thousand USD | 17.4% |
| 2008 Q3 | 265.66 Thousand USD | 121.05% |
| 2008 Q2 | 120.18 Thousand USD | -9.21% |
| 2008 FY | 852.26 Thousand USD | 31.96% |
| 2008 Q1 | 132.37 Thousand USD | -23.95% |
| 2008 Q4 | 334.04 Thousand USD | 25.74% |
| 2007 FY | 645.87 Thousand USD | 207.13% |
| 2007 Q4 | 174.07 Thousand USD | 26.09% |
| 2007 Q2 | 202.12 Thousand USD | 53.57% |
| 2007 Q1 | 131.62 Thousand USD | 266.84% |
| 2007 Q3 | 138.05 Thousand USD | -31.7% |
| 2006 Q4 | 35.88 Thousand USD | -61.09% |
| 2006 FY | 210.28 Thousand USD | 99.28% |
| 2006 Q2 | 28.78 Thousand USD | -46.11% |
| 2006 Q1 | 53.41 Thousand USD | -36.06% |
| 2006 Q3 | 92.21 Thousand USD | 220.37% |
| 2005 Q4 | 83.54 Thousand USD | 611.48% |
| 2005 Q2 | 7612.00 USD | 189.43% |
| 2005 Q1 | 2630.00 USD | -97.56% |
| 2005 FY | 105.52 Thousand USD | -74.43% |
| 2005 Q3 | 11.74 Thousand USD | 54.26% |
| 2004 FY | 412.61 Thousand USD | -98.23% |
| 2004 Q3 | 68.9 Thousand USD | -36.15% |
| 2004 Q2 | 107.91 Thousand USD | -98.06% |
| 2004 Q1 | 5.55 Million USD | -4.31% |
| 2004 Q4 | 107.62 Thousand USD | 56.2% |
| 2003 Q1 | 5.64 Million USD | -7.18% |
| 2003 FY | 23.29 Million USD | 2.33% |
| 2003 Q4 | 5.8 Million USD | -0.48% |
| 2003 Q3 | 5.82 Million USD | -3.22% |
| 2003 Q2 | 6.02 Million USD | 6.74% |
| 2002 Q2 | 5.85 Million USD | 18.23% |
| 2002 Q1 | 4.95 Million USD | -16.55% |
| 2002 FY | 22.76 Million USD | 4.3% |
| 2002 Q4 | 6.07 Million USD | 3.46% |
| 2002 Q3 | 5.87 Million USD | 0.34% |
| 2001 Q1 | 4.98 Million USD | 408.31% |
| 2001 Q4 | 5.93 Million USD | 9.74% |
| 2001 Q2 | 5.5 Million USD | 10.4% |
| 2001 Q3 | 5.4 Million USD | -1.66% |
| 2001 FY | 21.82 Million USD | 12.1% |
| 2000 FY | 19.46 Million USD | -33.55% |
| 2000 Q4 | -1.61 Million USD | -124.86% |
| 2000 Q3 | 6.5 Million USD | -16.16% |
| 2000 Q2 | 7.75 Million USD | 13.52% |
| 2000 Q1 | 6.83 Million USD | -12.43% |
| 1999 Q1 | 6.8 Million USD | -6.85% |
| 1999 Q2 | 7.1 Million USD | 4.41% |
| 1999 Q3 | 7.5 Million USD | 5.63% |
| 1999 FY | 29.3 Million USD | 12.26% |
| 1999 Q4 | 7.8 Million USD | 4.0% |
| 1998 Q4 | 7.3 Million USD | 17.74% |
| 1998 Q3 | 6.2 Million USD | -3.13% |
| 1998 Q2 | 6.4 Million USD | 1.59% |
| 1998 Q1 | 6.3 Million USD | -13.7% |
| 1998 FY | 26.1 Million USD | 17.04% |
| 1997 Q2 | 4.6 Million USD | -36.99% |
| 1997 Q1 | 7.3 Million USD | 58.7% |
| 1997 FY | 22.3 Million USD | 43.87% |
| 1997 Q4 | 7.3 Million USD | 19.67% |
| 1997 Q3 | 6.1 Million USD | 32.61% |
| 1996 Q4 | 4.6 Million USD | 15.0% |
| 1996 FY | 15.5 Million USD | 0.0% |
| 1996 Q3 | 4 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -176.723% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -121.988% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 29.801% |
| Avitar, Inc. | 3.1 Million USD | 36.329% |
| AVITA Medical, Inc. | 50.56 Million USD | 96.088% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.748% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -2183.527% |
| QHSLab, Inc. | 1.4 Million USD | -40.367% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.748% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 96.241% |
| Escalon Medical Corp. | 11.98 Million USD | 83.493% |
| Aurora Spine Corporation | 14.52 Million USD | 86.379% |
| BrainsWay Ltd. | 31.78 Million USD | 93.778% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -668.365% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 97.111% |
| Vivos Inc. | 19.5 Thousand USD | -10042.374% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.792% |
| Kelyniam Global, Inc. | 2.67 Million USD | 25.992% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -870.834% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -2240.991% |
| Nanomix Corporation | 15.45 Thousand USD | -12701.055% |
| Theraclion SA | 1.82 Million USD | -8.536% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -198.959% |
| Positron Corporation | 734.66 Thousand USD | -169.206% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -46.63% |
| Lombard Medical, Inc. | 12.16 Million USD | 83.748% |
| ALR Technologies Inc. | 7468.00 USD | -26383.168% |
| Stratec SE | 289.14 Million USD | 99.316% |
| Vycor Medical, Inc. | 1.46 Million USD | -35.407% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -390.112% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 90.304% |
| VMS Rehab Systems, Inc. | 71.70 USD | -2758286.332% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -1918.126% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -174.431% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 30.489% |
| Urologix, Inc. | 14.23 Million USD | 86.106% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 40.118% |
| SS Innovations International, Inc. | 5.87 Million USD | 66.363% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -4822.87% |
| Smith & Nephew plc | 5.68 Billion USD | 99.965% |
| NIOX Group Plc | 46.84 Million USD | 95.778% |
| Fuse Medical, Inc. | 16.11 Million USD | 87.728% |
| Broncus Holding Corporation | 10.25 Million USD | 80.714% |
| Brain Scientific Inc. | 214.56 Thousand USD | -821.759% |
| Health Logic Interactive Inc. | - USD | -Infinity% |